Contribution of multiparameter flow cytometry immunophenotyping to the diagnostic screening and classification of pediatric cancer.

Pediatric cancer is a relatively rare and heterogeneous group of hematological and non-hematological malignancies which require multiple procedures for its diagnostic screening and classification. Until now, flow cytometry (FC) has not been systematically applied to the diagnostic work-up of such ma...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cristiane S Ferreira-Facio, Cristiane Milito, Vitor Botafogo, Marcela Fontana, Leandro S Thiago, Elen Oliveira, Ariovaldo S da Rocha-Filho, Fernando Werneck, Danielle N Forny, Samuel Dekermacher, Ana Paula de Azambuja, Sima Esther Ferman, Paulo Antônio Silvestre de Faria, Marcelo G P Land, Alberto Orfao, Elaine S Costa
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/593fb01905c24092b3ea00ea295c75a7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:593fb01905c24092b3ea00ea295c75a7
record_format dspace
spelling oai:doaj.org-article:593fb01905c24092b3ea00ea295c75a72021-11-18T07:54:59ZContribution of multiparameter flow cytometry immunophenotyping to the diagnostic screening and classification of pediatric cancer.1932-620310.1371/journal.pone.0055534https://doaj.org/article/593fb01905c24092b3ea00ea295c75a72013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23472067/?tool=EBIhttps://doaj.org/toc/1932-6203Pediatric cancer is a relatively rare and heterogeneous group of hematological and non-hematological malignancies which require multiple procedures for its diagnostic screening and classification. Until now, flow cytometry (FC) has not been systematically applied to the diagnostic work-up of such malignancies, particularly for solid tumors. Here we evaluated a FC panel of markers for the diagnostic screening of pediatric cancer and further classification of pediatric solid tumors. The proposed strategy aims at the differential diagnosis between tumoral vs. reactive samples, and hematological vs. non-hematological malignancies, and the subclassification of solid tumors. In total, 52 samples from 40 patients suspicious of containing tumor cells were analyzed by FC in parallel to conventional diagnostic procedures. The overall concordance rate between both approaches was of 96% (50/52 diagnostic samples), with 100% agreement for all reactive/inflammatory and non-infiltrated samples as well as for those corresponding to solid tumors (n = 35), with only two false negative cases diagnosed with Hodgkin lymphoma and anaplastic lymphoma, respectively. Moreover, clear discrimination between samples infiltrated by hematopoietic vs. non-hematopoietic tumor cells was systematically achieved. Distinct subtypes of solid tumors showed different protein expression profiles, allowing for the differential diagnosis of neuroblastoma (CD56(hi)/GD2(+)/CD81(hi)), primitive neuroectodermal tumors (CD271(hi)/CD99(+)), Wilms tumors (>1 cell population), rhabdomyosarcoma (nuMYOD1(+)/numyogenin(+)), carcinomas (CD45(-)/EpCAM(+)), germ cell tumors (CD56(+)/CD45(-)/NG2(+)/CD10(+)) and eventually also hemangiopericytomas (CD45(-)/CD34(+)). In summary, our results show that multiparameter FC provides fast and useful complementary data to routine histopathology for the diagnostic screening and classification of pediatric cancer.Cristiane S Ferreira-FacioCristiane MilitoVitor BotafogoMarcela FontanaLeandro S ThiagoElen OliveiraAriovaldo S da Rocha-FilhoFernando WerneckDanielle N FornySamuel DekermacherAna Paula de AzambujaSima Esther FermanPaulo Antônio Silvestre de FariaMarcelo G P LandAlberto OrfaoElaine S CostaPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 3, p e55534 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Cristiane S Ferreira-Facio
Cristiane Milito
Vitor Botafogo
Marcela Fontana
Leandro S Thiago
Elen Oliveira
Ariovaldo S da Rocha-Filho
Fernando Werneck
Danielle N Forny
Samuel Dekermacher
Ana Paula de Azambuja
Sima Esther Ferman
Paulo Antônio Silvestre de Faria
Marcelo G P Land
Alberto Orfao
Elaine S Costa
Contribution of multiparameter flow cytometry immunophenotyping to the diagnostic screening and classification of pediatric cancer.
description Pediatric cancer is a relatively rare and heterogeneous group of hematological and non-hematological malignancies which require multiple procedures for its diagnostic screening and classification. Until now, flow cytometry (FC) has not been systematically applied to the diagnostic work-up of such malignancies, particularly for solid tumors. Here we evaluated a FC panel of markers for the diagnostic screening of pediatric cancer and further classification of pediatric solid tumors. The proposed strategy aims at the differential diagnosis between tumoral vs. reactive samples, and hematological vs. non-hematological malignancies, and the subclassification of solid tumors. In total, 52 samples from 40 patients suspicious of containing tumor cells were analyzed by FC in parallel to conventional diagnostic procedures. The overall concordance rate between both approaches was of 96% (50/52 diagnostic samples), with 100% agreement for all reactive/inflammatory and non-infiltrated samples as well as for those corresponding to solid tumors (n = 35), with only two false negative cases diagnosed with Hodgkin lymphoma and anaplastic lymphoma, respectively. Moreover, clear discrimination between samples infiltrated by hematopoietic vs. non-hematopoietic tumor cells was systematically achieved. Distinct subtypes of solid tumors showed different protein expression profiles, allowing for the differential diagnosis of neuroblastoma (CD56(hi)/GD2(+)/CD81(hi)), primitive neuroectodermal tumors (CD271(hi)/CD99(+)), Wilms tumors (>1 cell population), rhabdomyosarcoma (nuMYOD1(+)/numyogenin(+)), carcinomas (CD45(-)/EpCAM(+)), germ cell tumors (CD56(+)/CD45(-)/NG2(+)/CD10(+)) and eventually also hemangiopericytomas (CD45(-)/CD34(+)). In summary, our results show that multiparameter FC provides fast and useful complementary data to routine histopathology for the diagnostic screening and classification of pediatric cancer.
format article
author Cristiane S Ferreira-Facio
Cristiane Milito
Vitor Botafogo
Marcela Fontana
Leandro S Thiago
Elen Oliveira
Ariovaldo S da Rocha-Filho
Fernando Werneck
Danielle N Forny
Samuel Dekermacher
Ana Paula de Azambuja
Sima Esther Ferman
Paulo Antônio Silvestre de Faria
Marcelo G P Land
Alberto Orfao
Elaine S Costa
author_facet Cristiane S Ferreira-Facio
Cristiane Milito
Vitor Botafogo
Marcela Fontana
Leandro S Thiago
Elen Oliveira
Ariovaldo S da Rocha-Filho
Fernando Werneck
Danielle N Forny
Samuel Dekermacher
Ana Paula de Azambuja
Sima Esther Ferman
Paulo Antônio Silvestre de Faria
Marcelo G P Land
Alberto Orfao
Elaine S Costa
author_sort Cristiane S Ferreira-Facio
title Contribution of multiparameter flow cytometry immunophenotyping to the diagnostic screening and classification of pediatric cancer.
title_short Contribution of multiparameter flow cytometry immunophenotyping to the diagnostic screening and classification of pediatric cancer.
title_full Contribution of multiparameter flow cytometry immunophenotyping to the diagnostic screening and classification of pediatric cancer.
title_fullStr Contribution of multiparameter flow cytometry immunophenotyping to the diagnostic screening and classification of pediatric cancer.
title_full_unstemmed Contribution of multiparameter flow cytometry immunophenotyping to the diagnostic screening and classification of pediatric cancer.
title_sort contribution of multiparameter flow cytometry immunophenotyping to the diagnostic screening and classification of pediatric cancer.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/593fb01905c24092b3ea00ea295c75a7
work_keys_str_mv AT cristianesferreirafacio contributionofmultiparameterflowcytometryimmunophenotypingtothediagnosticscreeningandclassificationofpediatriccancer
AT cristianemilito contributionofmultiparameterflowcytometryimmunophenotypingtothediagnosticscreeningandclassificationofpediatriccancer
AT vitorbotafogo contributionofmultiparameterflowcytometryimmunophenotypingtothediagnosticscreeningandclassificationofpediatriccancer
AT marcelafontana contributionofmultiparameterflowcytometryimmunophenotypingtothediagnosticscreeningandclassificationofpediatriccancer
AT leandrosthiago contributionofmultiparameterflowcytometryimmunophenotypingtothediagnosticscreeningandclassificationofpediatriccancer
AT elenoliveira contributionofmultiparameterflowcytometryimmunophenotypingtothediagnosticscreeningandclassificationofpediatriccancer
AT ariovaldosdarochafilho contributionofmultiparameterflowcytometryimmunophenotypingtothediagnosticscreeningandclassificationofpediatriccancer
AT fernandowerneck contributionofmultiparameterflowcytometryimmunophenotypingtothediagnosticscreeningandclassificationofpediatriccancer
AT daniellenforny contributionofmultiparameterflowcytometryimmunophenotypingtothediagnosticscreeningandclassificationofpediatriccancer
AT samueldekermacher contributionofmultiparameterflowcytometryimmunophenotypingtothediagnosticscreeningandclassificationofpediatriccancer
AT anapauladeazambuja contributionofmultiparameterflowcytometryimmunophenotypingtothediagnosticscreeningandclassificationofpediatriccancer
AT simaestherferman contributionofmultiparameterflowcytometryimmunophenotypingtothediagnosticscreeningandclassificationofpediatriccancer
AT pauloantoniosilvestredefaria contributionofmultiparameterflowcytometryimmunophenotypingtothediagnosticscreeningandclassificationofpediatriccancer
AT marcelogpland contributionofmultiparameterflowcytometryimmunophenotypingtothediagnosticscreeningandclassificationofpediatriccancer
AT albertoorfao contributionofmultiparameterflowcytometryimmunophenotypingtothediagnosticscreeningandclassificationofpediatriccancer
AT elainescosta contributionofmultiparameterflowcytometryimmunophenotypingtothediagnosticscreeningandclassificationofpediatriccancer
_version_ 1718422730214211584